BriaCell Therapeutics Corp.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
BriaCell Therapeutics Corp. made a loss over the last year.
Compared with Healthcare companies in Canada.
P/E ratio
LossBriaCell Therapeutics Corp. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.29The share price is 1.29 times BriaCell Therapeutics Corp.'s book value per share, lower than 76% of Healthcare companies in Canada.
Market cap
C$44 MThe total market value of all of BriaCell Therapeutics Corp.'s shares at today's price (share price × number of shares), larger than 58% of Healthcare companies in Canada. PosiCap size class: Micro Cap.
Return on equity (ROE)
-175.3%BriaCell Therapeutics Corp. lost 175.3% of its shareholders' money over the last year, lower than 81% of Healthcare companies in Canada.
Dividend yield
NoneBriaCell Therapeutics Corp. does not currently pay a dividend.
Questions
What is BriaCell Therapeutics Corp.'s return on equity?
BriaCell Therapeutics Corp. lost 175.3% of its shareholders' money over the last year, lower than 81% of Healthcare companies in Canada.
Does BriaCell Therapeutics Corp. pay a dividend?
No. BriaCell Therapeutics Corp. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.